Top Buy
| Security | Buy | Sell ▼ | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Sarepta Therapeutics | 1 | 0 | 0 | 0 | €113.90 | €130.00 | 14.135% |
| MacroGenics Inc. | 13 | 0 | 4 | 0 | €4.18 | €12.42 | 196.957% |
| Biocryst Pharmaceuticals | 9 | 0 | 2 | 0 | €5.66 | €11.05 | 95.111% |
| Repligen Corp. | 13 | 0 | 1 | 0 | €144.45 | €184.76 | 27.906% |
| Fagron N.V. | 1 | 0 | 0 | 0 | €18.42 | €20.00 | 8.578% |
| Apellis Pharmaceuticals | 3 | 0 | 0 | 0 | €36.63 | €70.00 | 91.126% |
| Eli Lilly Corp. | 49 | 0 | 6 | 0 | €745.00 | €786.51 | 5.571% |
| Sanofi S.A. ADR | 9 | 0 | 0 | 0 | €44.80 | - | - |
| Esperion Therapeutis.Inc. | 15 | 0 | 3 | 0 | €1.96 | €8.55 | 336.217% |
| MorphoSys AG | 7 | 0 | 0 | 0 | €67.90 | €65.00 | -4.271% |
| Eledon Pharmaceuticals Inc. | 5 | 0 | 1 | 0 | €2.54 | €12.18 | 379.465% |
| AstraZeneca plc | 2 | 0 | 1 | 0 | €142.20 | €165.00 | 16.034% |
| Ardelyx Inc. | 2 | 0 | 0 | 0 | €6.35 | €11.00 | 73.174% |
| VBI Vaccines Inc. | 1 | 0 | 0 | 0 | €0.59 | €3.00 | 408.475% |
| Adverum Biotechnologies Inc. | 7 | 0 | 3 | 0 | €1.38 | €5.60 | 305.913% |
| Biolife Solutions Inc | 1 | 0 | 1 | 0 | €19.90 | - | - |
| Axsome Therapeutics Inc | 2 | 0 | 0 | 0 | €71.92 | €100.00 | 39.043% |
| Purple Biotech Ltd. ADR | 6 | 0 | 1 | 0 | €0.69 | €9.21 | 1234.565% |
| Rhythm Pharmaceuticals | 15 | 0 | 1 | 0 | €34.00 | €45.98 | 35.235% |
| Catalyst Pharmaceutical Partners Inc | 11 | 0 | 1 | 0 | €14.75 | €24.13 | 63.670% |
| Novo Nordisk A/S | 5 | 0 | 1 | 0 | €185.00 | €170.00 | -8.108% |
| Trinity Biotech ADR | 24 | 0 | 2 | 0 | €0.41 | - | - |
| Immutep LTD ADR | 1 | 0 | 0 | 0 | €2.62 | €4.00 | 52.672% |
| Verastem Inc. | 10 | 0 | 2 | 0 | €4.04 | €24.63 | 509.772% |
| Xeris Biopharma Holdings Inc. | 5 | 0 | 1 | 0 | €1.80 | €4.16 | 131.178% |